Julie Asch
Expertise in
6
conditions

Dr. Julie Asch

Hematology | Oncology
Optum
Budge Clinic Internal Medicine
Logan, UT 
On Staff At
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Expertise in
6
conditions
Optum
Budge Clinic Internal Medicine
Logan, UT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Acute Leukemia and Lymphoma and blood and marrow/Stem cell transplant.Professional interests: Adolescent and Young Adults, Acute Lymphoblastic Leukemia. Personal interests: Skiing, biking, music.

Dr. Asch is highly rated in 6 conditions, according to our data. Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 16 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Rutgers Medical School
Residency
Robert Wood Johnson University Hospital
Specialties
Hematology
Oncology
Licenses
Pediatric Hematology-Oncology in UT
Board Certifications
American Board Of Pediatrics
Fellowships
University of Utah
Hospital Affiliations
Intermountain Medical Center
Logan Regional Hospital
LDS Hospital
St George Regional Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Budge Clinic Internal Medicine
Logan, UT 84341
Call: 435-792-1980
Other Locations
Lds Hospital Physicians
8 Th Avenue C St, Salt Lake City, UT 84143
Call: 801-408-1100

Additional Areas of Focus

Dr. Asch has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
Enrollment Status: Recruiting
Publish Date: February 11, 2026
Intervention Type: Drug
A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL
A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL
Enrollment Status: Suspended
Publish Date: February 05, 2026
Intervention Type: Biological, Drug, Procedure, Other
Study Drugs: Allopurinol, Cytarabine, Daunorubicin Hydrochloride, Vincristine Sulfate, Dexamethasone, Pegylated L-Asparaginase, Methotrexate, Cyclophosphamide, Mercaptopurine, Rituximab, Doxorubicin, Thioguanine, Inotuzumab
Study Phase: Phase 3
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
Enrollment Status: Active_not_recruiting
Publish Date: November 28, 2025
Intervention Type: Drug, Procedure, Biological
Study Drugs: Blinatumomab, Cyclophosphamide, Cytarabine, Daunorubicin, Daunorubicin Hydrochloride, Dexamethasone, Etoposide, Mercaptopurine, Methotrexate, Pegaspargase, Prednisone, Rituximab, Vincristine, Vincristine Sulfate
Study Phase: Phase 3
An Open-label, Multi-center, Expanded Treatment Protocol of Midostaurin (PKC412) in Adult Patients With Newly Diagnosed Fms-like Tyrosine Kinase Receptor (FLT3) Mutated Acute Myeloid Leukemia (AML) Who Are Eligible for Standard Induction and Consolidation Chemotherapy.
An Open-label, Multi-center, Expanded Treatment Protocol of Midostaurin (PKC412) in Adult Patients With Newly Diagnosed Fms-like Tyrosine Kinase Receptor (FLT3) Mutated Acute Myeloid Leukemia (AML) Who Are Eligible for Standard Induction and Consolidation Chemotherapy.
Enrollment Status: No_longer_available
Publish Date: July 15, 2020
Intervention Type: Drug
View 3 Less Clinical Trials

16 Total Publications

Multiplexed gastrointestinal PCR panels for the evaluation of diarrhea in patients with acute leukemia.
Multiplexed gastrointestinal PCR panels for the evaluation of diarrhea in patients with acute leukemia.
Journal: Infection control and hospital epidemiology
Published: November 08, 2024
View All 16 Publications
Similar Doctors
Expertise in
17
conditions
Dr. Benjamin Maughan
Hematology
Expertise in
17
conditions
Dr. Benjamin Maughan
Hematology

Hematology-Oncology - Farmington

165 N University Ave, 
Farmington, UT 
 (14.3 miles away)
801-213-3200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Benjamin Maughan is a Hematologist in Farmington, Utah. Dr. Maughan is highly rated in 17 conditions, according to our data. His top areas of expertise are Prostate Cancer, Hemangioblastoma, Renal Cell Carcinoma (RCC), Penectomy, and Tissue Biopsy. Dr. Maughan is currently accepting new patients.

Expertise in
54
conditions
Dr. Jared Manning
Hematology
Expertise in
54
conditions
Dr. Jared Manning
Hematology

Logan Cancer Clinic

Logan, UT 
 (69.0 miles away)
435-176-1130
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jared Manning is a Hematologist in Logan, Utah. Dr. Manning is highly rated in 54 conditions, according to our data. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, and Diffuse Large B-Cell Lymphoma (DLBCL). Dr. Manning is currently accepting new patients.

Carl Gray
Expertise in
63
conditions
Dr. Carl Gray
Oncology
Expertise in
63
conditions
Dr. Carl Gray
Oncology

Ogden Clinic- Ogden UT Hematology Oncology

Ogden, UT 
 (26.5 miles away)
801-476-1777
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Carl Gray is an Oncologist in Ogden, Utah. Dr. Gray is highly rated in 63 conditions, according to our data. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Breast Cancer, Paget Disease of the Breast, and Lung Cancer. Dr. Gray is currently accepting new patients.

VIEW MORE Hematologists

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Asch's expertise for a condition
ConditionClose
    • Distinguished
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Asch is
      Distinguished
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Asch is
      Distinguished
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Advanced
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Asch is
      Advanced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Asch is
      Advanced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Childhood Acute Myeloid Leukemia
      Dr. Asch is
      Advanced
      . Learn about Childhood Acute Myeloid Leukemia.
      See more Childhood Acute Myeloid Leukemia experts
    • Myelodysplastic Syndrome (MDS)
      Dr. Asch is
      Advanced
      . Learn about Myelodysplastic Syndrome (MDS).
      See more Myelodysplastic Syndrome (MDS) experts
    • Experienced
    • Acute Myelomonocytic Leukemia
      Dr. Asch is
      Experienced
      . Learn about Acute Myelomonocytic Leukemia.
      See more Acute Myelomonocytic Leukemia experts
    • Acute Promyelocytic Leukemia
      Dr. Asch is
      Experienced
      . Learn about Acute Promyelocytic Leukemia.
      See more Acute Promyelocytic Leukemia experts
    • Agranulocytosis
      Dr. Asch is
      Experienced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Angioimmunoblastic T-cell Lymphoma
      Dr. Asch is
      Experienced
      . Learn about Angioimmunoblastic T-cell Lymphoma.
      See more Angioimmunoblastic T-cell Lymphoma experts
    • Aplastic Anemia
      Dr. Asch is
      Experienced
      . Learn about Aplastic Anemia.
      See more Aplastic Anemia experts
    • B-Cell Lymphoma
      Dr. Asch is
      Experienced
      . Learn about B-Cell Lymphoma.
      See more B-Cell Lymphoma experts
    View All 23 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    1. Homepage
    2. Hematologists Logan, UT
    3. Dr. Julie Asch
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      Once you submit your request, MediFind will reach out to the provider’s office to help schedule your appointment. Note that this is not a confirmed booking. You’ll receive a status update via email within 1–2 business days.

      Patient Details

      This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.